SEC Tracker
Get the app

Collegium Pharmaceutical COLL

Collegium Pharmaceutical terminates license agreement with Grunenthal

Item 1.02 Ends material agreement

Form
8-K
Filed
Importance
Notable
  1. Settlement agreement dated Oct 15, 2026
  2. $17M payment to Grunenthal
  3. Grunenthal assigned patents to COLL
  4. Nucynta Litigation dismissed

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Collegium Pharmaceutical files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Ardelyx ARDX public float $924M, Jun 30, 2025
  2. Viridian Therapeutics VRDN public float $943M, Jun 30, 2025
  3. CorMedix CRMD public float $910M, Jun 30, 2025
  4. Akebia Therapeutics AKBA public float $946M, Jun 30, 2025
  5. Neogen NEOG public float $972M, Nov 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.